Home
>
National Drug Code (NDC)
>
Depakene
Depakene - 0074-5681-13 - (Valproic Acid)
Drug Information of Depakene
| Product NDC: | 0074-5681 |
| Proprietary Name: | Depakene |
| Non Proprietary Name: | Valproic Acid |
| Active Ingredient(s): | 250 mg/1 & nbsp; Valproic Acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Depakene
| Product NDC: | 0074-5681 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018081 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19780228 |
Package Information of Depakene
| Package NDC: | 0074-5681-13 |
| Package Description: | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-5681-13) |
NDC Information of Depakene
| NDC Code | 0074-5681-13 |
| Proprietary Name | Depakene |
| Package Description | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-5681-13) |
| Product NDC | 0074-5681 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Valproic Acid |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 19780228 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | VALPROIC ACID |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
